DNA’s 39th Annual Convention Schedule
Friday, April 23, 2021
8:00 am – 9:00 am EST
General Session 301
Product Theater: TREMFYA: A First-line Biologic in Adult Patients with Moderate-to-Severe Plaque Psoriasis, Also Approved for Adults with Active Psoriatic Arthritis
Sponsored by Janssen Pharma (No CE)
Speaker: Sandri Johnson, MSN, FNP-BC
9:00 am – 9:15 am EST
9:15 am – 10:15 am EST
General Session 311
Topic/Title: Let’s Talk Skin: Atopic Dermatitis
A brief overview of the epidemiology, prevalence, presentation, and diagnosis of Atopic dermatitis. With a focus on both pharmacologic and non-pharmacologic options to assist with the treatment and management of the disease.
Speaker: Keischa Cash, DNP, APRN, FNP-BC
10:15 am – 10:30 am EST
10:30 am – 11:30 am EST
General Session 321
Topic/Title: Female Pattern Hair Loss: Navigating Cosmeceuticals and Nutraceuticals with our Patients
Female pattern hair loss (FPHL), also known as androgenic alopecia, is the most common form of hair loss seen in women. While there is rarely associated physical morbidity, the psychosocial impact has a significant on perceived well-being. Pharmacologic management options are limited for women, hair replacement and other medical procedures can be out of reach financially for many. The dermatology nurse and nurse practitioner be vital to help patients negotiate marketing claims and help guide decisions by having knowledge of the available evidence and helping patients evaluate online resources.
Speaker: Katrina Nice Masterson, DNP, RN, FNP-BC, DCNP
11:30 am – 11:45 am EST
11:45 am – 12:45 pm EST
General Session 331
Topic/Title: Psoriais in the 2020’s: Formerly Known as The Heartbreak of Psoriasis
This presentation will be an advanced and comprehensive discussion of all aspects of psoriasis, including a detailed introduction, epidemiology, pathophysiology, clinical presentation, prognosis, and management of the psoriatic patient. By the end of the presentation, the attendee should have a firm understanding of all aspects of the clinical manifestations of psoriasis and its management.
Speaker: Abel Jarell, MD, FAAD
12:45 pm – 1:00 pm EST
1:00 pm – 2:00 pm EST
General Session 341
Product Theater: What Sets Taltz Apart: An Overview of Long-Term Safety and Efficacy
Sponsored by Lilly USA (No CE)
Speaker: Lakshi Aldredge, MSN, ANP-BC, DCNP
2:00 pm – 2:15 pm EST
2:15 pm – 3:15 pm EST
General Session 351
Topic/Title: Top 5 Diagnoses Seen By Dermatology NPs
Top 5 Diagnoses Seen By Dermatology NPs description: This presentation will discuss the Top 5 most common diagnoses seen by Dermatology nurse practitioners. We will briefly cover diagnosis, etiology, treatment options, and pearls for patient care.
Speaker: Heather Onoday, FNP-C, DCNP
3:15 pm – 3:30 pm EST
3:30 pm – 4:30 pm EST
General Session 361
Topic/Title: Ethnic Dermatology
We are called to recognize disparities in access to quality healthcare provided to ethnic communities. While there are still a limited number of ethnically diverse clinicians currently practicing in dermatology in the US, there is an increasing body of literature which addresses Ethnic Dermatology. This presentation compiles a literature review of relevant historical, cultural and clinical information from experts in this discipline to enhance the knowledge base, and therefore the quality of care, in caring for patients with skin of color.
Speaker: Victoria Lazareth, MA, MSN, NP-C, DCNP
4:30 pm – 4:45 pm EST
4:45 pm – 5:45 pm EST
General Session 371
Topic/Title: Comedy Show
Laugh and Learn how humor reduces pain, improves mood, lowers stress hormones, boosts immunity, expedites creative problem solving and bonds us with our team. Recognize the symptoms of stress and when humor is most needed, and how to use humor appropriately in stressful situations and create an environment that invites humor that bonds team members.
Speaker: Nancy Norton, RN